May 15, 2017 12:04 pm UTC| Business
HOPKINTON, Mass., May 15, 2017 -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory...
May 15, 2017 12:04 pm UTC| Business
HOPKINTON, Mass., May 15, 2017 -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory...
May 15, 2017 12:04 pm UTC| Business
HOPKINTON, Mass., May 15, 2017 -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and inflammatory...
May 15, 2017 12:03 pm UTC| Business
RICHMOND, Calif., May 15, 2017 -- Thomas Looby, President and Chief Executive Officer of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company delivering solutions for medical and industrial markets,...
May 15, 2017 12:03 pm UTC| Business
RICHMOND, Calif., May 15, 2017 -- Thomas Looby, President and Chief Executive Officer of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company delivering solutions for medical and industrial markets,...
May 15, 2017 12:03 pm UTC| Business
RICHMOND, Calif., May 15, 2017 -- Thomas Looby, President and Chief Executive Officer of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company delivering solutions for medical and industrial markets,...
AMAG Pharmaceuticals Completes Financing Transactions in Support of Future Growth Strategy
May 15, 2017 12:03 pm UTC| Business
WALTHAM, Mass., May 15, 2017 -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that it has paid in full the remaining balance of $321 million of its term loan, which was due in 2021. This transaction, as well...